LYRA THERAPEUTICS INC's ticker is LYRA and the CUSIP is 55234L105. A total of 39 filers reported holding LYRA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $15,836,352 | -2.6% | 4,050,218 | +2.3% | 1.35% | -14.0% |
Q2 2023 | $16,265,497 | +264.4% | 3,957,542 | +78.2% | 1.57% | +359.9% |
Q1 2023 | $4,463,868 | -36.0% | 2,220,830 | 0.0% | 0.34% | -24.3% |
Q4 2022 | $6,973,406 | -38.0% | 2,220,830 | -1.1% | 0.45% | -37.9% |
Q3 2022 | $11,252,000 | -16.0% | 2,245,830 | -5.2% | 0.73% | +8.5% |
Q2 2022 | $13,389,000 | – | 2,369,668 | – | 0.67% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 2,780,261 | $10,870,821 | 3.33% |
Perceptive Advisors | 12,757,562 | $49,882,067 | 1.66% |
Nantahala Capital Management | 4,050,218 | $15,836,352 | 1.35% |
PURA VIDA INVESTMENTS, LLC | 1,413,242 | $5,525,776 | 1.04% |
Ikarian Capital, LLC | 1,254,384 | $4,904,641 | 0.59% |
Parkman Healthcare Partners LLC | 625,056 | $2,443,969 | 0.45% |
VR Adviser, LLC | 924,170 | $3,613,505 | 0.38% |
Soleus Capital Management, L.P. | 592,417 | $2,316,350 | 0.21% |
ARMISTICE CAPITAL, LLC | 1,550,000 | $6,060,500 | 0.09% |
Clearline Capital LP | 119,128 | $465,790 | 0.04% |